RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

   
   

This invention relates to compounds, compositions, and methods useful for modulating Angiopoietin gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of Angiopoietin gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (mRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of Angiopoietin genes, such as Angiopoietin-1 (Ang-1), Angiopoietin-2 (Ang-2), Angiopoietin-3 (Ang-3), and Angiopoietin-4 (Ang-4).

 
Web www.patentalert.com

< Ultrasonic treatment device

< System and method for detecting an involuntary muscle movement disorder

> Extracellular junctional adhesion molecules

> Method for the immunohistological detection of fibrogenesis in histological tissue sections using antiboides against C-terminal procollagen alpha1 (III) propeptide

~ 00195